Monday, November 06, 2006 4:42:36 PM
rogerreuss, smart entry and exit on BCON -congrats! You knew that any stock that goes straight up like that -you'd better grab your profits before the sell off. I feel more comfortable this time about NGNM since its rise is happening over a longer period in stages/bases. One still has to watch out for warning/sell signs like a high volume plummet through the 50 day. At some point people will want to take their profit in this stock but I'm guessing it will be a gradual fall not abrupt. Few people know about NGNM yet and we are still in early in this rise yet. Most likely scenario for this company is they will be bought out by Quest Diagnostics (DGX) or Laboratory Corp (LH) at a 50% premium in a couple of years. But then again Gasparini & Jones might not want to sell their baby...
That's good insight on the upcoming $1.75 & $2.00 hurdles. Yes, it usually takes a couple of pull-backs before overtaking future resistance levels.
The rise this year was in part the result of Neogenomics hiring Hawk Associates to promote the stock and provide analyst coverage. NGNM is paying them almost 7K a month for these and investor relation services. I must say though that their analyst, Cale Smith, writes an excellent report and he is even critical at times. Keep in mind though at the moment we have a company that will only net about 500k this year and is 1.5M in debt. But based on Gasparini and his teams past performance and the high-margin market they are in and the 25 to 45% annual growth predicted...we should see a continued escalation of the stock price...just got to be careful that it doesn't get too far out of line but so far we have had high volume to support the rise.
Recent NEO News
- NeoGenomics to Participate in the Piper Sandler 36th Annual Healthcare Conference • Business Wire • 11/08/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/05/2024 09:11:56 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 11/05/2024 09:10:42 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/05/2024 09:06:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/05/2024 12:14:34 PM
- NeoGenomics Reports Third Quarter 2024 Results • Business Wire • 11/05/2024 12:00:00 PM
- NeoGenomics Receives New York State Approval for Neo Comprehensive™ Solid Tumor Test • Business Wire • 10/22/2024 12:10:00 PM
- NeoGenomics to Report Third Quarter 2024 Financial Results on Nov. 5, 2024 • Business Wire • 10/15/2024 11:30:00 AM
- NeoGenomics Launches AML Express for Rapid Genetic Profiling of Acute Myeloid Leukemia • Business Wire • 10/08/2024 12:10:00 PM
- NeoGenomics Announces New RaDaR Technology and Resolution of RaDaR 1.0 Litigation • Business Wire • 09/23/2024 10:47:00 PM
- NeoGenomics to Present New Data at ESMO 2024, Highlighting the Value of ctDNA and NGS for Advancing Cancer Diagnostics and Personalized Treatment • Business Wire • 09/11/2024 12:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/04/2024 08:08:12 PM
- NeoGenomics to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference • Business Wire • 08/29/2024 12:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/19/2024 08:19:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/19/2024 08:17:28 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/15/2024 08:29:16 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/15/2024 08:12:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/13/2024 08:40:44 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/13/2024 08:37:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/13/2024 08:34:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/13/2024 08:32:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/13/2024 08:27:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/13/2024 08:24:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/13/2024 08:21:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/13/2024 08:17:15 PM
Avant Technologies and Ainnova Tech Form Joint Venture to Advance Early Disease Detection Using Artificial Intelligence • AVAI • Nov 12, 2024 9:00 AM
Swifty Global Announces Launch of Swifty Sports IE, Expanding Sports Betting and Casino Services in the Irish Market • DRCR • Nov 12, 2024 9:00 AM
Oohvie App Update Enhances Women's Health with Telemedicine and Online Scheduling • HLYK • Nov 11, 2024 8:00 AM
SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM
DBG Pays Off $1.3 Million in Convertible Notes, which Retires All of the Company's Convertible Notes • DBGI • Nov 7, 2024 2:16 PM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service • SMX • Nov 7, 2024 8:48 AM